Montelukast in the management of allergic rhinitis

Figures & data

Table 1 Revised classification of AR from ARIA guidelines. Copyright © 1992. Reproduced with permission from Corren J, Adinoff AD, Irvin CG. 1992. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol, 90:250–6.

Classification of allergic rhinitis

“Intermittent” means that the symptoms are present: Less than 4 days a week, Or for less than 4 weeks. “Persistent” means that the symptoms are present: More than 4 days a week, And for more than 4 weeks. “Mild” means that none of the following items are present: Sleep disturbance, Impairment of daily activities, leisure and/or sport, Impairment of school or work, Troublesome symptoms. “Moderate-severe” means that one or more of the following items are present: Sleep disturbance, Impairment of daily activities, leisure and/or sport, Impairment of school or work, Troublesome symptoms.

Abbreviations: AR, allergic rhinitis;ARIA, Allergic Rhinitis and its Impact on Asthma.